Apyx Medical Corp (APYX) stock
Close on Nov 11, 2026Market cap $126.37MP/E –Yield –
Apyx Medical Corp grew revenue 24.4% to $59.57M over the twelve months to Sep 30, 2026. Free cash flow was -$8.89M. At the latest close the market valued the company at $126.37M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $126.37M
- P/E ratio
- –
- Price to sales
- 2.12
- Price to book
- 13.12
- Dividend yield
- –
- Free cash flow yield
- -7.04%
Fundamentals
- Revenue
- $59.57M
- Net income
- -$8.44M
- EPS, diluted
- -$0.19
- Free cash flow
- -$8.89M
- Book value per share
- $0.22
- Diluted shares
- 44M
Trading
- Next earnings
- Mar 9, 2027 (estimated, before the open)
- Previous close
- $2.93
- Open
- $3.08
- Day's range
- $2.92 – $3.10
- Volume
- 34,178
- Average volume (20 days)
- 160,395
- Beta (5 years)
- 1.49
- 52-week range
- $2.25 – $5.08
- RSI (14 days)
- 62.9
- Volatility (1 year)
- 73.8%
- Relative volume
- 0.26×
- WACC
- 12.2%
Market cap history
Month-end market cap since 2010, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | APYX | S&P 500 | Difference | APYX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +15.8% | -2.4% | +18.2 pts | ||
| 3 months | -0.7% | -1.2% | +0.5 pts | ||
| Year to date | -14.3% | +12.3% | −26.6 pts | ||
| 1 year | -25.0% | +12.4% | −37.4 pts | ||
| 3 years | +70.9% | +78.8% | −7.9 pts | +19.6% | +21.4% |
| 5 years | -79.5% | +75.2% | −154.6 pts | -27.1% | +11.9% |
| 10 years | -24.4% | +311.1% | −335.5 pts | -2.8% | +15.2% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Apyx Medical filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- News
- Results
- News
- News
- News
About Apyx Medical
Surgical & Medical Instruments & Apparatus
Apyx Medical Corporation is an energy-based medical technology company focused on surgical aesthetics. The company operates through two main business segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its core offerings feature helium plasma technology marketed under the Renuvion and AYON Body Contouring System brand names for the cosmetic surgery market, as well as J-Plasma for hospital surgical procedures. These systems integrate electrosurgical generators and single-use handpieces to deliver precise thermal energy to tissue. The company also manufactures generators and components for other medical device makers under OEM contracts. In the United States, Apyx Medical sells directly to cosmetic surgeons, surgical centers, and medical offices, while utilizing distributor networks for international distribution.
Company profile, executives and historyApyx Medical stock: common questions
What is Apyx Medical's stock price?
APYX closed at $3.00 on Nov 11, 2026, up 2.39% on the day. Over the past 52 weeks it traded between $2.25 and $5.08.
What is Apyx Medical's market cap?
Apyx Medical was worth $126.37M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is APYX's P/E ratio?
Apyx Medical lost money over the twelve months to Sep 30, 2026 (diluted EPS -$0.19), so it has no meaningful P/E ratio.
How much revenue does Apyx Medical make?
Apyx Medical reported revenue of $59.57M for the twelve months to Sep 30, 2026, up 24.4% from a year earlier.
Does Apyx Medical pay a dividend?
No. Apyx Medical has not paid a cash dividend over the last twelve months.
When does Apyx Medical report earnings next?
Apyx Medical is expected to report Q4 FY2026 results on Mar 9, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has APYX stock performed over the past year?
Including dividends, APYX returned -25.0% over the past year, against +12.4% for the S&P 500.
How many APYX shares are sold short?
0M shares were sold short at the latest FINRA report, 0.62% of the float, or 2.1 days of average trading volume.
Who are Apyx Medical's competitors?
Companies most similar to Apyx Medical by business, industry and size include RCEL, LNSR, TELA, MHUAF, CARL.
See a number that looks wrong?